|
Delayed
Bombay S.E.
17:41:50 17/11/2026 HKT
|
5-day change | 1st Jan Change | ||
| 2,253.10 INR | -3.90% |
|
-9.74% | +23.59% |
Company Valuation: Caplin Point Laboratories Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 51,529 | 45,291 | 100,038 | 152,221 | 114,409 | 178,206 | - |
| Change | - | -12.11% | 120.88% | 52.16% | -24.84% | 55.76% | - |
| Enterprise Value (EV) | 51,529 | 45,291 | 100,038 | 152,221 | 114,409 | 178,206 | 178,206 |
| Change | - | -12.11% | 120.88% | 52.16% | -24.84% | 55.76% | 0% |
| P/E | 17.3x | 12.1x | 22x | 28.5x | 17.9x | 24.1x | 21.1x |
| PBR | 3.47x | 2.41x | 4.32x | 5.34x | 3.19x | 4.17x | 3.51x |
| PEG | - | 0.5x | 1x | 1.6x | 0.9x | 1.5x | 1.5x |
| Capitalization / Revenue | 4.06x | 3.09x | 5.91x | 7.86x | 5.23x | 7.13x | 6.29x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 7.13x | 6.29x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 20.2x | 17.7x |
| EV / EBIT | 0x | 0x | - | 0x | 0x | 19.1x | 16.5x |
| EV / FCF | 0x | 0x | 0x | 0x | 0x | 29.7x | 31.5x |
| FCF Yield | 4.77% | 1.72% | 1.73% | 1.58% | 2.4% | 3.37% | 3.17% |
| Dividend per Share 2 | 2 | 2 | 2.5 | 3 | - | 4 | 4 |
| Rate of return | 0.29% | 0.34% | 0.19% | 0.15% | - | 0.17% | 0.17% |
| EPS 2 | 39.26 | 49.18 | 59.9 | 70.25 | 84.11 | 97.3 | 110.8 |
| Distribution rate | 5.09% | 4.07% | 4.17% | 4.27% | - | 4.11% | 3.61% |
| Net sales 1 | 12,694 | 14,667 | 16,941 | 19,375 | 21,872 | 25,008 | 28,340 |
| EBITDA 1 | 3,947 | 4,411 | 5,514 | 6,469 | 7,609 | 8,819 | 10,066 |
| EBIT 1 | 3,478 | 4,520 | - | 5,810 | 8,036 | 9,349 | 10,784 |
| Net income 1 | 2,998 | 3,763 | 4,571 | 5,363 | 6,412 | 7,391 | 8,424 |
| Net Debt | - | - | - | - | - | - | - |
| Reference price 2 | 679.90 | 596.70 | 1,317.30 | 2,002.60 | 1,505.15 | 2,344.45 | 2,344.45 |
| Nbr of stocks (in thousands) | 75,789 | 75,903 | 75,942 | 76,012 | 76,012 | 76,012 | - |
| Announcement Date | 12/5/22 | 27/5/23 | 16/5/24 | 15/5/25 | 14/5/26 | - | - |
1INR in Million2INR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 24.1x | - | - | - | 1.9B | ||
| 41.9x | 14.18x | 30.07x | 0.48% | 1,275B | ||
| 41.35x | 6.94x | 19.51x | 1.89% | 680B | ||
| 37.55x | 8.61x | 17.78x | 2.34% | 521B | ||
| 22x | 5.33x | 13.34x | 2.45% | 389B | ||
| 102.54x | 5.86x | 24.97x | 2.35% | 356B | ||
| 24.41x | 5.87x | 14.28x | 2.7% | 305B | ||
| 24.28x | 4.86x | 13.64x | 1.8% | 287B | ||
| 23.87x | 7.33x | 13.47x | 2.18% | 250B | ||
| -39.41x | 7.29x | 45.94x | 1.97% | 208B | ||
| Average | 30.26x | 7.36x | 21.45x | 2.02% | 427B | |
| Weighted average by Cap. | 37.07x | 8.89x | 22.51x | 1.69% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CAPLIPOINT Stock
- Valuation Caplin Point Laboratories Limited
Select your edition
All financial news and data tailored to specific country editions
















